Shifting the Balance: Mitochondrial Heteroplasmy as a Driver of Cardiac Disease
Circulation Research · 14.08.2026 · 139 (5)
DOI: 10.1161/circresaha.126.328769 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Circulation Research, erschienen am 14.08.2026. Verfasst von Andriana Papadaki und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, University Medical Center Groningen, University of Groningen, the Netherlands (A.P., I.B.D., P.v.d.M., N.B.). Hauptthemen laut MEDLINE: Mitochondria, Heart, Heart Diseases, Heteroplasmy, DNA, Mitochondrial. Die Arbeit nennt 201 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Mitochondrial heteroplasmy represents a fundamental determinant of mitochondrial function and disease, yet its consequences vary across different tissues. Although mitotic tissues possess mechanisms, such as cell division and mitochondrial turnover, to dilute or remove deleterious variants, postmitotic tissues lack this renewal capacity and are disproportionately vulnerable. Neuromuscular and neurodegenerative disorders have illustrated the impact of heteroplasmic mutations, but the (postmitotic) heart remains underexplored. Current reliance on blood-derived samples provides only an indirect view of cardiac heteroplasmy, highlighting the need for alternative approaches, such as endomyocardial biopsies and human induced pluripotent stem cell–derived cardiomyocytes. Expanding cardiac-focused research is essential for identification, clarifying pathogenesis, improving risk stratification, and guiding patient monitoring. Emerging therapies, including mitochondrial transplantation and mitochondrial-targeted DNA editing, demonstrate potential to modulate heteroplasmy and restore equilibrium. Integrating these strategies with precision medicine will be vital for addressing tissue-specific vulnerabilities. Ultimately, bridging the gap in cardiac heteroplasmy research will be critical for translating basic mitochondrial biology into meaningful clinical advances.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, University Medical Center Groningen, University of Groningen, the Netherlands (A.P., I.B.D., P.v.d.M., N.B.).
- Department of Translational Science, University Clinic Würzburg, Germany (C.M.).
- Department of Internal Medicine I, University Hospital Würzburg, Germany (C.M.).
ORCID-Profile: Itamar Braga Dias, Christoph Maack, Peter van der Meer, Nils Bomer
Zitieren
APA
Papadaki, A., Braga Dias, I., Maack, C., van der Meer, P., & Bomer, N. (2026). Shifting the Balance: Mitochondrial Heteroplasmy as a Driver of Cardiac Disease. Circulation Research, 139(5). https://doi.org/10.1161/circresaha.126.328769
Vancouver
Papadaki A, Braga Dias I, Maack C, van der Meer P, Bomer N. Shifting the Balance: Mitochondrial Heteroplasmy as a Driver of Cardiac Disease. Circulation Research. 2026;139(5). doi:10.1161/circresaha.126.328769
BibTeX
@article{Papadaki2026,
author = {Papadaki, Andriana and Braga Dias, Itamar and Maack, Christoph and van der Meer, Peter and Bomer, Nils},
title = {Shifting the Balance: Mitochondrial Heteroplasmy as a Driver of Cardiac Disease},
journal = {Circulation Research},
year = {2026},
volume = {139},
number = {5},
doi = {10.1161/circresaha.126.328769}
}
EUVIMED